Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX004 in Cystic Fibrosis with Chronic Pseudomonas aeruginosa
NCT06998043Phase 2Recruiting
- Sponsor
- BiomX
- Start
- Jul 2025
- Primary completion
- Mar 2026
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of BX004 in Pseudomonas aeruginosa infection, sponsored by BiomX. Started Jul 2025; status: recruiting.
02
Drugs
BX004
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT06998043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998043.